Ventrus Biosciences Inc. (VTUS) was a big mover last session, as its shares rose around 7% on the day. This continues the recent uptrend for the company, as the stock is now up over 15% in the past one-month time frame.
In the last 60 days, the healthcare company witnessed three positive estimate revisions and its Zacks Consensus Estimate also moved higher, suggestive of more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can translate into more strength down the road.
Ventrus currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some other medical stocks worth considering include Lannett Company, Inc. (LCI), Jazz Pharmaceuticals plc (JAZZ) and Questcor Pharmaceuticals, Inc. (QCOR). All these companies carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
VENTRUS BIOSCIENCES INC (VTUS): Free Stock Analysis Report
LANNETT COMP (LCI): Free Stock Analysis Report
JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report
QUESTCOR PHARMACEUTICALS INC (QCOR): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Health Care Industry